17-beta-hydroxysteroid dehydrogenase deficiency ultrasound: Difference between revisions
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{17-beta-hydroxysteroid dehydrogenase deficiency}} | {{17-beta-hydroxysteroid dehydrogenase deficiency}} | ||
Ultrasound of [[abdomen]] and [[pelvis]] showed absence of [[uterus]] or [[vagina]]. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} |
Revision as of 11:07, 1 April 2022
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
17-beta-hydroxysteroid dehydrogenase deficiency ultrasound On the Web |
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound |
FDA on 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound |
CDC on 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound |
17-beta-hydroxysteroid dehydrogenase deficiency ultrasound in the news |
Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound |
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency ultrasound |
Ultrasound of abdomen and pelvis showed absence of uterus or vagina.